vimarsana.com

Practice Guidelines For The Administration Of Buprenorphine News Today : Breaking News, Live Updates & Top Stories | Vimarsana

FDA s Overdose Prevention Framework Aims to Prevent Drug Overdoses and Reduce Death - US Politics Today

An Opportunity for Bipartisan Action: Congress and the Biden-Harris Administration Respond to Growing Mental Health and Substance Use Challenges | Akin Gump Strauss Hauer & Feld LLP

HHS Issues Buprenorphine Practice Guidelines as Study Confirms Access Barriers | Mintz - Health Care Viewpoints

Dept of Health Buprenorphine for Treating Opioid Use Disorder Guidance

Wednesday, June 9, 2021 One of the spillover effects of the COVID-19 pandemic has been the increase in opioid-related deaths. These deaths overwhelmingly affect working-class Americans with limited access and resources to lifesaving drugs such as buprenorphine and naloxone. As a result, the Department of Health and Human Services (HHS) issued the Practice Guidelines for the Administration of Buprenorphine for Treating Opioid Use Disorder (Practice Guidelines) through a waiver of certain certification requirements prescribed by law. The Practice Guidelines remove a longtime prerequisite tied to training and counseling that several practitioners have cited as a barrier to treating patients with Opioid Use Disorder (OUD). The Practice Guidelines could not come soon enough, as a recent study indicates that individuals with OUD experienced decreased access to treatments during the pandemic.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.